628567699 | PUO | 85842554 | | 3664842 | 5/26/2007 12:00:00 AM | Gemella morbillorum bacteremia and possible endocarditis | | DIS | Admission Date: 2/21/2007 Report Status: Discharge Date: 9/29/2007 ****** FINAL DISCHARGE ORDERS ****** CYNOVA , JAKE D 491-68-62-3 MI Service: MED DISCHARGE PATIENT ON: 1/15/07 AT 03:00 PM CONTINGENT UPON Attending evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: FANIEL , GAYLENE G. , M.D. CODE STATUS: Full code DISPOSITION: Rehabilitation MEDICATIONS ON ADMISSION: 1. ACETAMINOPHEN 650 MG PO Q6H 2. ACETYLSALICYLIC ACID 325 MG PO QD 3. ALBUTEROL NEBULIZER 2.5 MG NEB Q4H 4. DOCUSATE SODIUM 100 MG PO BID 5. FLUTICASONE NASAL SPRAY 2 SPRAY NA QD 6. HEPARIN 5000 UNITS SC Q8H 7. INSULIN GLARGINE 32 UNITS SC QHS 8. KCL SLOW RELEASE TAB 40 MEQ PO BID 9. NIFEREX 150 150 MG PO BID 10. PANTOPRAZOLE 40 MG PO Q12 11. 
SENNOSIDES 2 TAB PO BID 12. SIMVASTATIN 40 MG PO QHS 13. ALBUTEROL NEBULIZER 2.5 MG NEB Q12H 14. 
SARNA UNKNOWN TOP UNKNOWN 15. 
FUROSEMIDE 80 MG PO QAM 16. FLUTICASONE PROPIONATE 110 MCG ORAL INHALER 2 PUFFS INH BID 17. INSULIN LISPRO SLIDING SCALE SC 18. LOSARTAN 50 MG PO QD 19. 
THERAPEUTIC MULTIVITAMINS 1 TAB PO QD 20. MAALOX EXTRA STRENGTH UNKNOWN PO UNKNOWN 21. POLYETHYLENE GLYCOL 17 GM PO QD 22. DIPHENHYDRAMINE 25 MG PO UNKNOWN 23. 
BISACODYL UNKNOWN PO UNKNOWN MEDICATIONS ON DISCHARGE: MICONAZOLE NITRATE 2% POWDER TOPICAL TP BID Instructions: apply to pannus ACETYLSALICYLIC ACID 325 MG PO DAILY ALBUTEROL NEBULIZER 2.5 MG NEB Q6H PRN Wheezing ALBUTEROL NEBULIZER 2.5 MG NEB Q12H NEOMYCIN/POLY B/BACITRACIN OINTMENT ( BACITRAC... ) TOPICAL TP DAILY Instructions: apply to right hand lesion Alert overridden: Override added on 3/10/07 by : POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; NEOMYCIN SULFATE , TOPICAL OR OPHTH Reason for override: aware DULCOLAX ( BISACODYL ) 5 MG PO DAILY PRN Constipation CEFTRIAXONE 2 , 000 MG IV DAILY Starting Today ( 5/2 ) Instructions: to end 11/7/07 COLACE ( DOCUSATE SODIUM ) 100 MG PO BID FLUTICASONE NASAL SPRAY 1 SPRAY NA BID FLOVENT HFA ( FLUTICASONE PROPIONATE INH ) 110 MCG INH BID LASIX ( FUROSEMIDE ) 80 MG PO QAM Starting IN AM ( 7/26 ) Alert overridden: Override added on 7/25/07 by HORA , LATARSHA T. , M.D. , M.P.H. on order for LASIX PO ( ref # 533742872 ) Pt. has a POSSIBLE allergy to Sulfa; reaction is Unknown. 
Reason for override: no reaction Previous Alert overridden Override added on 7/25/07 by HORA , LATARSHA T. , M.D. , M.P.H. POTENTIALLY SERIOUS INTERACTION: GENTAMICIN SULFATE &amp; FUROSEMIDE Reason for override: aware GENTAMICIN SULFATE 80 MG IV DAILY Starting Today ( 5/2 ) Instructions: to continue at least for 2 weeks ( until 11/27/07 ) Override Notice: Override added on 7/25/07 by HORA , LATARSHA T. , M.D. , M.P.H. on order for LASIX PO ( ref # 533742872 ) POTENTIALLY SERIOUS INTERACTION: GENTAMICIN SULFATE &amp; FUROSEMIDE Reason for override: aware Previous override information: Override added on 7/25/07 by HORA , LATARSHA T. , M.D. , M.P.H. on order for LASIX INJ IV ( ref # 914108730 ) POTENTIALLY SERIOUS INTERACTION: GENTAMICIN SULFATE &amp; FUROSEMIDE , INJ Reason for override: aware HEPARIN 5 , 000 UNITS SC Q8H Instructions: please give as instructed until pt out of bed and ambulatory. 
LANTUS ( INSULIN GLARGINE ) 36 UNITS SC BEDTIME HOLD IF: please give 1/2 dose if NPO LISPRO ( INSULIN LISPRO ) Sliding Scale ( subcutaneous ) SC AC Low Scale Call HO if BS less than 60 If BS is less than 125 , then DO NOT Administer supplemental ( sliding scale ) insulin If BS is 125-150 , then give 0 units subcutaneously If BS is 151-200 , then give 1 units subcutaneously If BS is 201-250 , then give 2 units subcutaneously If BS is 251-300 , then give 3 units subcutaneously If BS is 301-350 , then give 4 units subcutaneously If BS is 351-400 , then give 5 units subcutaneously Call HO if BS is greater than 350 If ordered QAC administer at same time as , and in addition to , standing insulin aspart order. 
If ordered HS administer alone K-DUR ( KCL SLOW RELEASE TAB ) 40 MEQ PO BID As per PUO Potassium Chloride Policy: each 20 mEq dose to be given with 4 oz of fluid NIFEREX 150 150 MG PO BID PANTOPRAZOLE 40 MG PO Q12H MIRALAX ( POLYETHYLENE GLYCOL ) 17 GM PO DAILY PRN Constipation Number of Doses Required ( approximate ): 4 SARNA TOPICAL TP DAILY PRN Itching SENNA TABLETS ( SENNOSIDES ) 2 TAB PO BID SIMVASTATIN 40 MG PO BEDTIME Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
Override Notice: Override added on 11/18/07 by CHANT , VONNIE F. , M.D. , M.P.H. on order for MULTIVITAMIN THERAPEUTIC PO ( ref # 294155663 ) POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN , VIT. B-3 Reason for override: md aware MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... ) 1 TAB PO DAILY Alert overridden: Override added on 11/18/07 by CHANT , VONNIE F. , M.D. , M.P.H. POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN , VIT. B-3 Reason for override: md aware DIET: Fluid restriction DIET: House / ADA 1800 cals/dy DIET: 2 gram Sodium ACTIVITY: Walking as tolerated FOLLOW UP APPOINTMENT( S ): Dr. Chanelle Tikkanen 10/29/07 12:45PM scheduled , Dr. Dulcie Scovel ( Infectious Disease Clinic ) 7/19/07 8am scheduled , Dr. Christine Dario , please call for follow up upon discharge from rehab , ALLERGY: Sulfa , TETRACYCLINE ADMIT DIAGNOSIS: bacteremia PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Gemella morbillorum bacteremia and possible endocarditis OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay chf ( congestive heart failure ) dm ( diabetes mellitus ) cad ( coronary artery disease ) af ( atrial fibrillation ) htn ( hypertension ) hypercholesterolemia ( elevated cholesterol ) OPERATIONS AND PROCEDURES: none OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) TEE 6/18/07 BRIEF RESUME OF HOSPITAL COURSE: CC: fever , +blood cx , r/o endocarditis -------- HPI: 82 year old man w/ PMH s/f AVR for aortic stenosis ( August , 2007 ) , HTN , hyperlipidemia , CAD s/p CABG , CHF ( ef 60% 6/12 ) , atrial fibrillation w/ SVR , IDDM , Fe def anemia and hemorrahgic stroke ( ~6 months ago ) who was transferred from Whitein Bapdell Medical Center due to fever ( 2 days prior to presentation ) and positive UA and blood culture significant for gram positive cocci in clusters. 
Concern that patient may have endocarditis. 
No other systemic signs or symptoms. 
------- PMH: s/p AVR ( 11/29 ) , htn , hyperlipidemia , cad w/ cabg x3 , a fib w/ svr , iddm , anemia , s/p hemorrhagic stroke 9/21 , bph , s/p suprapubic cath placement -------- HOME MEDS:albuterol , asa , sarna , colace , fluticasone , lasix 80 qam , lispro SS , lantus 32u qhs , simvastatin , tylenol prn , senna , losartan , mvi iron , kcl , protonix , maalox , dulcolax , benadryl , miralax ------- ALL: sulfa--swelling; tetracycline--swelling ------- ADMIT EXAM: VS: 98.5F , hr 49 , bp160/56 , sat 99%ra gen-nad; heent-o/p clear , no icterius; neck-fupple , no lan , fvp to ear; cv-brady irreg irreg , 4/8 sem at lusb; pulm-crackles at bases b/l; abd-benign; no stigmata of endocarditis; extr-1+ pitting edema to ankles b/l , 1+pulses b/l , wwp ----- ADMIT LABS: CR 1.9 ( baseline 1.3 ) , hct 31 ( baseline 29 ) , wbc 8 ------- DATA: CXR: improved L pleural effusion EKG: a fib@44 , lad , rbbb , old q's inf ( unchanged from prior ) From Rehab: 10/22 gpc in chains ( ?2/4 bottles ) Echo ( TTE ) 1/8 EF 60-65% mild LVH with restrictive filling defect , mild LAE/RAE , AoV peak grad 52mmHg , mean 2mmHg , peak AoV velocity 3.6 m/s ( elevated but stable )trace MR , Trace TR , PAP 31 +RAP , no veg. 
U/A: 3+LE , 7wbc , 1+bact UCx: 10 , 000 colonies probable pseudomonas 9/16 BCx: Gemella morbillorum ( pansensitive ) , PCN MIC 0.125 ( intermediate ) Wound Cx of suprapubic cath insertion site: rare MRSA , few CNS , rare enterococci TEE: negative for ring abscess or valvular vegetation. 
------- A/P: 8 Y/O M w/ mult med problems , s/p recent AVR , transferred from rehab w/ fever , +U/A , +blood cx's , with concern for endocarditis given recent AVR. 
Patient was started on ceftaz and vanco empirically , then was changed to ceftriaxone and gentamycin once Gemella morbillorum was identified on in-house blood cultures. 
Patient remained afebrile in-house and did not exhibit any significant leukocytosis , or stigmata of endocardititis. 
Surveillance cultures drawn after starting antibiotics have remained negative to date. 
-------- 1. Cardiovascular ischemia: No CP/CT/CD. 
Hx of CAD s/p CABG continue w/ aspirin 325mg PO QD rhythm: pt w hx of AF w/ SVR. 
Patient placed on telemetry for observation. 
Is bradycardic at baseline , asymptomatic has refused PPM in the past per report. 
Some runs NSVT up to 14 beats , checking BID lytes keep Mg&gt;2 and K.4 , no nodal agents given bradycardia. 
Pump: hx CHF documented , last EF 60%. 
pt appears fluid up , responded well to 60 IV lasix x1. 
Pt then appeared euvolemic and lasix was held , for sev days and became hypervolemic , lasix 60mg IV repeated and patient restarted on home lasix dose ( 80mg QAM ). 
Patient's discharge weight is 96.7kg. 
His dry weight is approximately 93KG. 
Discharge weight is 96.7kg. 
His in/out goal is 500cc neg daily. 
-TTE neg for veg , but given high risk , TEE obtained on 7/4 to assess for possible endocarditis. 
Was negative for ring abscess or valvular vegetationn. 
Pt will still require treatement for endocarditis as cannot be entirely ruled out. 
Held losartan due to acute worsening of renal function as well as initiation of gentamycin. 
Pt can resume use once gent is discontinued. 
2. Renal: Cr slightly elevated above baseline ( 1.1-1.3 ) on admit , likely 2/2 CHF and poor forward flow has declined to near baseline and was 1.4 at time of d/c. 3. GU: Pt has hx of BPH and has a suprapubic cathether that was inserted at the time of surgery due to difficulty to pass foley. 
At TH pt has been clamped repeatedly over the last week w/ PVR checked. 
Pt without difficulty in house w/ PVR of 50cc. 
Urology consulted and suprapubic catheter pulled without difficulty. 
Cont dry sterile dressing daily to wound. 
3. ID-Gemella morbillorum in blood , Pseudomonas in urine although only 10k colonies. 
Pt treated with 5 days of ceftaz , and 4 days vanc. 
Decision was made to d/c ceftaz given only 10K colonies Pseudomonas in urine and some coverage with ceftriaxone and gent ( started 10/8 ) d/c'd vanc 10/24 Will need 6 wks ctx and at least 2 wks gent for presumed endocarditis. 
PICC placed 10/8 4. GI -continue protonix 40 Q12 all stools guaiac negative in house. 
5. Endocrine -hx of IDDM will titrate up insulin to 36U qHS w/ insluin aspart SS 6. FEN -cardiac diet -cont MVI -BID lytes w/ goal to keep K/Mg March 7. GI -continue senna and colace 8. Pulm -cont flovent 2 puffs BID and albuterol q12h 9. Heme: cont niferex BID for iron deficiency anemia. 
Pt also with mild eosinophilia on diff , should be monitored. 
10. 
Derm: skin tear on right hand , placing neomycin ointment and sterile dry dressing daily. 
Prophylaxis-cont heparin 5000 TID -cont protonix 40Q12h FULL CODE ADDITIONAL COMMENTS: You were admitted to the hospital with a bacterial blood infection and possible heart valve infection. 
You were treated with intravenous antibiotics and improved. 
PLAN: 1. Continue ceftriaxone for 6 weeks to end 11/7/07 and gentamycin to continue for at least 2 weeks ( at least until 11/27/07 ) 2. Please go to your follow up appointment with Dr. Dulcie Scovel in the infectious disease clinic at the Kernan To Dautedi University Of Of on 7/19/07 at 8AM. 3. Please go to your follow up appointment with Dr. Tikkanen on 10/29/07 at 12:45PM. 
4. Please call Dr. Neal Kruel office for follow up upon discharge from rehab. 5. Please stop taking your home losartan medicine while you are on antibiotics. 
Dr. Dario can decide when to restart this medicine. 
6. 
After leaving rehab , if you are still on antibiotics , please have your blood drawn twice a week. 
Your results will be sent to Dr. Sabal 7. If you have fever , sweats chills , rash , worsening shortness of breath , or chest pain please contact your physician or return to the ER. 8. Continue all other home meds. 
9. Continue low salt , low fat , low cholesterol diet , continue to restrict all fluids to 2 liters daily. 
DISCHARGE CONDITION: Stable TO DO/PLAN: 1. Please check basic metabolic panel twice daily while actively diuresing on lasix. 
Then check basic metabilic panel twice weekly to be to follow lytes and creatinine while on antibiotics. 
2. Please draw CBC with differential once weekly while on gent and ceftriaxone. 
3. Please draw gent trough once weekly and adjust gent dose as needed. 
4. Infectious Disease consultant to determine whether gentamicin should be continued beyond 2 weeks 5. Consider surveillance blood cultures 1 week after completing antibiotic therapy to document clearance. 
6. Please place neomycin ointment to right hand lesion daily and cover with dry sterile dressing once daily. 
7. Cont dry sterile dressing to suprpubic cath site daily until healed. 
8. Consider repeat urine cultures 2 weeks after d/c to document clearance of pseudomonas. 
9. Consider restarting losartan after gentamicin is discontinued given underlying renal insufficiency. 
10. 
Please follow up pending blood cultures ( no growth to date at time of discharge. 
) 11. Please do daily weights on patient. 
No dictated summary ENTERED BY: HORA , LATARSHA T. , M.D. , M.P.H. ( LZ161 ) 8/1/07 @ 11 ****** END OF DISCHARGE ORDERS ******